On June 24, 2024, Guangzhou LBP Medicine Science & Technology announced that Nanjing Qianjing has accumulated the sale of 680,033 shares of the company's stocks, accounting for 0.73% of the total share capital of the company, through bulk trading. After the equity change, Nanjing Qianjing holds 4,678,385 shares of the company's stocks, accounting for 5% of the total share capital of the company.
安必平：南京乾靖减持股份 不再是公司持股5%以上的股东
Guangzhou LBP Medicine Science & Technology: Nanjing Qianjing reduces its shareholding, is no longer a shareholder holding more than 5% of the company's shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.